| Name | Title | Contact Details |
|---|
WE HELP ATHLETES PUSH LIMITS, CHALLENGE THE STATUS QUO AND STRIVE FOR THAT WHICH IS BEYOND THE HORIZON. Using insights from mountain athletes we have brought to market innovative products such as the Stretch Puffy Jacket focused on solving problems and delivering performance. SYNC is a fast growing performance sport brand building technical apparel for the mountain athlete. Through our single-mindedness and commitment to performance we have been able to deliver true innovation to our consumers.
AprotekUSA turns YOUR liquid waste stream into a solid in real-time. SAVE MONEY💲 BY SOLIDIFYING YOUR SLUDGE 🌎We specialize in the recycling and manufacture of super-absorbent products. Since 2013, weve been working with public and private companies to solve their problems relating to sludge containment, water absorption and retention, impermeability and liquid solidification. Our core business? MUDS and LIQUID DEBLAYS. 💩 Our range of APROMUD® super-settlers is formidable when it comes to solidifying sludge, whatever its origin or composition. Sludge from construction sites, WWTPs, HDD, tunneling, mines & quarries, pond cleaning, concrete plants, drilling we have developed low-carbon solutions to make it easier for you to handle, transport and recycle your sludge while saving you . 🌱
Acrisure Re is a leading re/insurance intermediary and corporate advisor/broker dealer, offering bespoke and innovative capital, risk, and program solutions. Our expert multi-disciplinary team leverage their combined experience, market data and leading analytics to provide the very best placement and execution strategies. Operating in Bermuda, Florida, Italy, London, Minnesota, New York, North Carolina, Seattle, Toronto and Zurich, our global team of experienced and talented employees are dedicated to driving a sophisticated, tech-enabled future for the (re)insurance industry.
Since 1950, United Community has been dedicated to providing best-in-class service to our customers as the foundation of every relationship. Were proud to have won several awards for our service. In eight of the last ten years, J.D. Power ranked United highest in customer satisfaction with retail banking in the Southeast. Forbes included United in its inaugural list of the Worlds Best Banks in 2019, and again in 2020, 2022 and 2023. We were also recognized on the Forbes 2020 list of the 100 Best Banks in America for the seventh consecutive year. We received five Greenwich Excellence Awards in 2019 for excellence in Small Business Banking and Middle Market Banking, including a national award for Overall Satisfaction in Small Business Banking. Were honored to be recognized as a great place to work, too. In 2020, we were designated one of the Top Workplaces in South Carolina (Greenville Business Magazine) and Atlanta (Atlanta Journal-Constitution). With more than 200 banking locations throughout Alabama, Georgia, North Carolina, South Carolina, Tennessee, and Florida, we provide a full range of consumer and commercial banking products to fit your unique needs. If you want a better banking experience, visit your local United Community today and allow our team to deliver the personal attention you deserve. Visit ucbi.com to learn more about the products and services we offer. Before engaging with our online community (including our social media channels), please refer to our Community Guidelines: ucbi.com/social-media The social media policy covers acceptable use by the public and our employees in conjunction with our Privacy Policy: ucbi.com/privacy-policy Equal Housing Lender | Member FDIC.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.